Fulton Breakefield Broenniman’s Chevron CVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.1M Sell
24,721
-942
-4% -$175K 0.24% 64
2026
Q1
$5.31M Sell
25,663
-246
-0.9% -$44.9K 0.35% 55
2025
Q4
$3.95M Sell
25,909
-760
-3% -$116K 0.25% 62
2025
Q3
$4.14M Buy
26,669
+3,580
+16% +$554K 0.27% 59
2025
Q2
$3.31M Sell
23,089
-73,176
-76% -$10.3M 0.22% 64
2025
Q1
$16.1M Buy
96,265
+1,865
+2% +$292K 1.16% 28
2024
Q4
$13.7M Buy
94,400
+1,028
+1% +$157K 0.98% 34
2024
Q3
$13.8M Buy
93,372
+223
+0.2% +$33.2K 0.96% 37
2024
Q2
$14.6M Buy
93,149
+767
+0.8% +$122K 1.08% 35
2024
Q1
$14.6M Buy
92,382
+5,299
+6% +$800K 1.12% 34
2023
Q4
$13M Buy
87,083
+3,569
+4% +$540K 1.04% 38
2023
Q3
$14.1M Buy
83,514
+2,960
+4% +$478K 1.22% 31
2023
Q2
$12.7M Buy
80,554
+3,651
+5% +$585K 1.05% 42
2023
Q1
$12.5M Sell
76,903
-257
-0.3% -$43.1K 1.08% 40
2022
Q4
$13.8M Buy
77,160
+1,432
+2% +$250K 1.23% 36
2022
Q3
$10.9M Buy
75,728
+1,072
+1% +$163K 1.02% 39
2022
Q2
$10.8M Sell
74,656
-888
-1% -$147K 0.93% 43
2022
Q1
$12.3M Sell
75,544
-14,622
-16% -$2.1M 1.08% 39
2021
Q4
$10.6M Buy
90,166
+87
+0.1% +$9.88K 0.78% 50
2021
Q3
$9.14M Sell
90,079
-413
-0.5% -$41.2K 0.78% 50
2021
Q2
$9.48M Buy
90,492
+577
+0.6% +$60.9K 0.81% 49
2021
Q1
$9.42M Buy
89,915
+10,323
+13% +$1.01M 0.87% 49
2020
Q4
$6.72M Sell
79,592
-23,272
-23% -$1.88M 0.81% 51
2020
Q3
$7.41M Sell
102,864
-5,478
-5% -$461K 0.83% 48
2020
Q2
$9.67M Sell
108,342
-1,136
-1% -$102K 1.17% 41
2020
Q1
$7.93M Sell
109,478
-2,333
-2% -$231K 1.18% 41
2019
Q4
$13.5M Buy
111,811
+182
+0.2% +$21.4K 1.57% 22
2019
Q3
$13.2M Sell
111,629
-219
-0.2% -$26.6K 1.68% 20
2019
Q2
$13.9M Buy
111,848
+1,128
+1% +$136K 2.2% 12
2019
Q1
$13.6M Buy
110,720
+764
+0.7% +$90.4K 2.21% 12
2018
Q4
$12M Buy
109,956
+16,515
+18% +$1.91M 2.11% 12
2018
Q3
$11.4M Buy
93,441
+556
+0.6% +$67.5K 1.78% 19
2018
Q2
$11.7M Buy
92,885
+3,073
+3% +$381K 1.88% 13
2018
Q1
$10.2M Sell
89,812
-224
-0.2% -$26.8K 1.78% 18
2017
Q4
$11.3M Sell
90,036
-485
-0.5% -$57.5K 1.89% 15
2017
Q3
$10.6M Buy
90,521
+386
+0.4% +$42.1K 1.85% 12
2017
Q2
$9.4M Buy
90,135
+725
+0.8% +$76.8K 1.68% 17
2017
Q1
$9.6M Buy
89,410
+1,675
+2% +$188K 1.78% 16
2016
Q4
$10.3M Sell
87,735
-488
-0.6% -$53.1K 2.04% 11
2016
Q3
$9.08M Buy
88,223
+571
+0.7% +$58.3K 1.84% 15
2016
Q2
$9.19M Buy
87,652
+15,870
+22% +$1.6M 1.87% 13
2016
Q1
$6.85M Buy
71,782
+12,481
+21% +$1.09M 1.5% 24
2015
Q4
$5.33M Sell
59,301
-796
-1% -$71.8K 1.18% 37
2015
Q3
$4.74M Buy
60,097
+783
+1% +$65.9K 1.12% 41
2015
Q2
$5.72M Buy
59,314
+331
+0.6% +$34.8K 1.25% 35
2015
Q1
$6.19M Buy
58,983
+1,183
+2% +$126K 1.38% 27
2014
Q4
$6.48M Buy
57,800
+2,016
+4% +$229K 1.42% 28
2014
Q3
$6.66M Buy
55,784
+82
+0.1% +$10.5K 1.56% 17
2014
Q2
$7.27M Buy
55,702
+460
+0.8% +$57.2K 1.76% 13
2014
Q1
$6.57M Buy
55,242
+735
+1% +$85.5K 1.69% 16
2013
Q4
$6.81M Sell
54,507
-1,395
-2% -$169K 1.8% 10
2013
Q3
$6.79M Buy
55,902
+1,337
+2% +$164K 1.83% 10
2013
Q2
$6.46M Buy
+54,565
New +$6.59M 1.89% 8

Other funds holding CVX

Fulton Breakefield Broenniman's CVX Position: Q2 2026 in Review

Fulton Breakefield Broenniman reduced its Chevron (CVX) stake by 3.7% in Q2 2026, selling an estimated $175K and leaving 24,721 shares worth $4.1M. The position accounts for 0.24% of the portfolio, ranked #64.

Fulton Breakefield Broenniman first reported a position in CVX in Q2 2013 and has held it in 53 quarters since. The position peaked at $16.1M in Q1 2025. 2,476 funds tracked by Wall St. Rank hold CVX as of Q2 2026.

  • Fulton Breakefield Broenniman held 24,721 shares of Chevron worth $4.1M as of Q2 2026.
  • Fulton Breakefield Broenniman sold 942 Chevron shares in Q2 2026, an estimated $175K.
  • Chevron made up 0.24% of Fulton Breakefield Broenniman's portfolio in Q2 2026, its #64 holding.
  • Fulton Breakefield Broenniman first reported a position in Chevron in Q2 2013 and has held it in 53 quarters since.
  • Fulton Breakefield Broenniman's Chevron position peaked at $16.1M in Q1 2025.
  • 2,476 funds tracked by Wall St. Rank held Chevron as of Q2 2026.

Based on Fulton Breakefield Broenniman's 13F filing for Q2 2026, filed 3 Aug 2026.